NeuroEM Therapeutics
144 E. Boca Raton Road
Phoenix
Arizona
85022
United States
Tel: 480-395-1481 or 602-466-2179
Website: http://neuroem.com/
Email: gary.arendash@neuroem.com
About NeuroEM Therapeutics
NeuroEM Therapeutics is developing and plans to market a self-contained head device that, if clinically successful, will provide “in home” electromagnetic treatment to the brains of Alzheimer’s patients. While providing treatment for one to two hours per day, the head device will not hinder daily activities. We believe the device will directly attack the Alzheimer’s Disease process. It would be available through neurologists and other health professions who diagnosis memory disorders.YEAR FOUNDED:
2013
LEADERSHIP:
CEO and President: Gary W. Arendash, PhD
Director of Clinical Assessment: Dr. Chuanhai Cao
TECHNOLOGY:
Please click here for NeuroEM's technology.
5 articles about NeuroEM Therapeutics
-
Bioengineered Head Device Stops Alzheimer's Memory Loss for 2.5 Years
8/3/2022
There is no therapeutic that has been shown to stop or reverse the devastating memory loss of Alzheimer's Disease.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Alzheimer's Memory Loss Reversed by Easy-to-Wear Head Device from NeuroEM Therapeutics
8/6/2019
NeuroEM Therapeutics, a clinical stage medical device company focused on neurodegenerative diseases, today announced findings from an early stage study, which assessed safety and initial efficacy of transcranial electromagnetic treatment (TEMT) with the company's investigational MemorEM™ head device for Alzheimer's disease (AD)
-
NIH Bestows Grant To NeuroEM Therapeutics And Arizona State University For Collaborative Research In Alzheimer's Disease
12/8/2016
-
NeuroEM Therapeutics Release: Alzheimer's Clinical Trial Begins With Pioneering Medical Device
12/6/2016